The 50th Annual Oncology Nursing Society (ONS) Congress is scheduled to take place from April 9-13, 2025, in Denver, Colorado. This significant event provides a unique opportunity for oncology nursing professionals to gather and celebrate the rich history of their field while also looking ahead to the future of cancer care. As the largest conference dedicated to oncology nursing, attendees can expect a comprehensive program featuring over 70 sessions tailored to various educational tracks and session types. This diverse selection ensures that participants can easily find content that aligns with their professional goals, regardless of where they currently stand in their career journey.
To secure your attendance at this event, we highly recommend registering promptly by clicking this link. By doing so, you will have the chance to secure accommodations, access travel information, plan your itinerary, and guarantee your participation in educational and networking activities before they reach full capacity.
Below, you will find a list of sessions focused on Multiple Myeloma (MM) that we are looking forward to at the ONS Congress. The sessions are organized in chronological order for your convenience.
A Consideration for Patients with Relapsed or Refractory Multiple Myeloma
- Date: Wednesday, April 9, 2025
- Time: 11:15 AM - 12:45 PM
- Location: Centennial A-C (Hyatt Regency)
- Description: Join for this lunch symposium tailored to offer a comprehensive educational session on two bispecific antibody products developed by Johnson & Johnson.
CAR-T Therapy in Relapsed Refractory Multiple Myeloma: An Overview for Patient Care Teams
- Date: Thursday, April 10, 2025
- Time: 6:00 AM - 7:30 AM
- Location: Centennial FGH (Hyatt Regency)
- Description: This is a non-CME breakfast symposium designed to provide nurses and advanced practice providers with a detailed understanding of CAR-T therapy in patients with relapsed refractory multiple myeloma. Join for an in-depth discussion on the latest advancements in this cutting-edge treatment approach.
- Date: Thursday, April 10, 2025
- Time: 11:15 AM - 12:05 PM
- Location: Theater 2 (Colorado Convention Center)
- Description: This program offers a comprehensive overview of treatment considerations for frontline Multiple Myeloma treatment. Participants will gain insight into the benefits of DARZALEX and DARZALEX FASPRO, as well as their effectiveness in combination with VRd for Induction and Consolidation in newly diagnosed patients eligible for Autologous Stem Cell Transplant (PERSEUS Trial). Additionally, attendees will learn about the use of DARZALEX in Combination with RD alone for newly diagnosed patients who are ineligible for Autologous Stem Cell Transplant (MAIA Trial). The program will also cover important safety information and provide a detailed program summary.
Case Studies for Nurses: Treatment Updates and Patient Care Insights in Multiple Myeloma
- Thursday, April 10, 2025
- 12:15 PM - 1:45 PM
- Location: Centennial DE (Hyatt Regency)
- Description: Advancements in the treatment of multiple myeloma are progressing quickly, both in initial treatment and in care for patients who have experienced a relapse. This 1.5 Continuing Nursing Education (CNE) symposium will delve into the latest developments in upfront quad regimens, bispecifics, CAR T therapy, emerging therapies like CELMoDs, and more. Our knowledgeable nurse presenters will use case studies to illustrate the differences between various treatments, with a focus on topics such as minimal residual disease (MRD), treatment sequencing, bridging therapies, treatment duration, managing adverse events, and coordinating care with community healthcare centers. Attendees can expect to receive practical tips and access to downloadable tools to enhance their practice.
Charting the Nursing Course in Relapsed/Refractory Multiple Myeloma with Novel Targeted Therapies
- Date: Thursday, April 10, 2025
- Time: 6:00 PM - 7:30 PM
- Location: Centennial A-C (Hyatt Regency)
- Description: This will be an engaging and informative symposium that will delve into the crucial role of oncology nurses in managing relapsed/refractory multiple myeloma (MM). The esteemed faculty will provide insights into recent clinical data and draw from their own experiences to guide learners through the ever-changing treatment landscape. Topics will include the use of novel targeted therapies such as bispecific antibody therapies, CAR T-cell therapies, and antibody drug conjugates. Practical considerations will be emphasized to showcase best practices for treating and managing adverse events in this patient population. Don't miss this opportunity to enhance your knowledge and skills in caring for patients with MM.
- Date: Saturday, April 12, 2025
- Time: 11:15 AM - 12:05 PM
- Location: Theater 1 (Colorado Convention Center)
- Description: The presentation offers valuable insights and best practices for fostering partnerships between institutions in order to effectively initiate, transition, and manage patients with relapsed or refractory multiple myeloma who are undergoing a cutting-edge therapeutic advancement aimed at stimulating a tumor-specific immune response.
The 2025 ONS Congress is set to be an enriching and informative event. We recommend clicking here to explore the comprehensive list of topics and sessions that will be covered at this significant event. Don’t miss the opportunity to expand your expertise — register today.
Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our recap post the conference.
Copyright © 2025 Guideline Central, All Rights Reserved.